Liposomes mimic human cell membranes and protect active ingredients until they reach the intestines, ensuring optimal nutrient delivery and bioavailability
They help to lower your blood sugar by triggering insulin release and blocking sugar production
More recently, encouraging clinical results from a triple-hormone-receptor agonist, Retatrutide, and several GLP-1R/GCGR dual agonists, suggest that GCGR could be a promising co-stimulating target for type 2 diabetes and obesity.
This timeline aligns with metabolic correction: insulin sensitivity improves within 46 weeks, systemic inflammation markers decline by 810 weeks, and dopamine signaling may normalize as metabolic health stabilizes
SUPLEMENTO ALIMENTARIO Su uso no es recomendable para menores de 8 aos, embarazadas y nodrizas, salvo indicacin profesional competente y no reemplaza a una alimentacin balanceada